New Leaf Biopharma Opportunities II, L.P.

Insider Reports History

Location
New York, NY
Signature
New Leaf Ventures III, L.P., By: New Leaf Venture Associates III, L.P., its general partner, By: New Leaf Venture Management III, L.L.C., its general partner, By: /s/ Craig Slutzkin, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by New Leaf Biopharma Opportunities II, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Harpoon Therapeutics, Inc. Director, 10%+ Owner 8.000% Series A Redeemable Preferred Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 11 Mar 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 11 Mar 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 11 Mar 2024 Indirect

Insider Reports Filed by New Leaf Biopharma Opportunities II, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024029449-new-leaf-biopharma-opportunities-ii-l-p-2024-03-11 Harpoon Therapeutics, Inc. 11 Mar 2024 6 $0 4 Director, 10%+ Owner 11 Mar 2024, 17:28
/report/000089924323020044-new-leaf-biopharma-opportunities-ii-l-p-2023-10-25 Harpoon Therapeutics, Inc. 25 Oct 2023 4 $0 4 10%+ Owner 27 Oct 2023, 16:41
/report/000089924323009744-new-leaf-biopharma-opportunities-ii-l-p-2023-03-23 Harpoon Therapeutics, Inc. 23 Mar 2023 0 $0 3 10%+ Owner 27 Mar 2023, 17:49